Viridian Therapeutics, Inc. (VRDN)
18.66
+0.32
(+1.74%)
USD |
NASDAQ |
Oct 09, 16:00
18.69
+0.03
(+0.16%)
After-Hours: 20:00
Viridian Therapeutics 30-Day Average Daily Volume : 1.741M for Oct. 9, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 09, 2026 | 1.741M |
| October 08, 2026 | 1.725M |
| October 07, 2026 | 1.669M |
| October 06, 2026 | 1.643M |
| October 05, 2026 | 1.608M |
| October 02, 2026 | 1.549M |
| October 01, 2026 | 1.535M |
| September 30, 2026 | 1.483M |
| September 29, 2026 | 1.503M |
| September 28, 2026 | 1.525M |
| September 25, 2026 | 1.517M |
| September 24, 2026 | 1.506M |
| September 23, 2026 | 1.485M |
| September 22, 2026 | 1.492M |
| September 21, 2026 | 1.519M |
| September 18, 2026 | 1.516M |
| September 17, 2026 | 1.480M |
| September 16, 2026 | 1.493M |
| September 15, 2026 | 1.509M |
| September 14, 2026 | 1.530M |
| September 11, 2026 | 1.523M |
| September 10, 2026 | 1.532M |
| September 09, 2026 | 1.557M |
| September 08, 2026 | 1.541M |
| September 04, 2026 | 1.554M |
| Date | Value |
|---|---|
| September 03, 2026 | 1.579M |
| September 02, 2026 | 1.584M |
| September 01, 2026 | 1.624M |
| August 31, 2026 | 1.628M |
| August 28, 2026 | 1.666M |
| August 27, 2026 | 1.711M |
| August 26, 2026 | 1.753M |
| August 25, 2026 | 1.780M |
| August 24, 2026 | 1.788M |
| August 21, 2026 | 1.790M |
| August 20, 2026 | 1.807M |
| August 19, 2026 | 1.838M |
| August 18, 2026 | 1.834M |
| August 17, 2026 | 1.884M |
| August 14, 2026 | 1.878M |
| August 13, 2026 | 1.907M |
| August 12, 2026 | 1.957M |
| August 11, 2026 | 2.019M |
| August 10, 2026 | 2.171M |
| August 07, 2026 | 2.288M |
| August 06, 2026 | 2.295M |
| August 05, 2026 | 2.195M |
| August 04, 2026 | 2.195M |
| August 03, 2026 | 2.207M |
| July 31, 2026 | 2.281M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Vertex Pharmaceuticals, Inc. | 1.034M |
| TG Therapeutics, Inc. | 1.816M |
| Travere Therapeutics, Inc. | 1.702M |
| ACADIA Pharmaceuticals, Inc. | 2.105M |
| Alnylam Pharmaceuticals, Inc. | 1.492M |